Inmune Bio, Inc.

INMB

Inmune Bio, Inc.

INMB

Insider Sentiment (TTM):

Last Purchase:2024-09-30Last Sale:2023-07-12Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:5,338,854Shares Outstanding:26,585,258Institutional Ownership Pct.:20.08%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Related Party	-	0	0	-0	0	0	0	-0	0	0	0	0
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	18	21	25	28	33	19	21	34	31	26	36	42
Accounts Receivable Net Current	4	0	4	2	2	1	1	1	3	-	2	-
Other Receivables Net Current	0	0	0	1	1	0	0	0	0	1	1	0
Prepaid Expense And Other Assets Current	1	1	1	0	1	0	0	1	1	1	2	2
Assets Current	24	23	30	31	36	21	23	36	35	30	40	46
Property Plant And Equipment Net	1	1	1	1	1	-	-	-	-	-	-	-
Operating Lease Right Of Use Asset	1	1	1	1	0	0	0	0	0	0	0	0
Other Assets Noncurrent	1	1	1	1	1	0	0	0	0	0	0	0
Intangible Assets Net Excluding Goodwill	-	-	-	-	-	17	17	17	17	17	17	17
Assets	27	26	32	33	38	38	40	53	52	47	57	63
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	5	5	8	7	8	7	7	11	9	9	8	4
Other Liabilities Current	-	-	-	-	1	0	1	1	1	1	0	0
Other Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	10
Long Term Debt Current	-	-	-	-	-	-	-	2	5	7	10	-
Operating Lease Liability Current	1	1	1	0	0	0	0	0	0	0	0	0
Liabilities Current	6	5	8	7	9	8	7	14	15	17	18	14
Other Long Term Debt Noncurrent	-	-	-	-	-	-	-	-	-	-	-	2
Operating Lease Liability Noncurrent	1	1	0	1	0	0	0	0	0	0	0	0
Liabilities	6	6	9	8	9	8	7	14	15	18	19	18
Stockholders Equity
Accounts Payable And Accrued Liabilities Noncurren…	-	-	-	-	-	-	-	-	-	-	-	1
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	-	-	-	1	1	1	1
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	238	235	233	230	227	203	196	194	179	161	159	157
Accumulated Other Comprehensive Income Loss Net Of…	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1
Retained Earnings Accumulated Deficit	-216	-214	-209	-204	-197	-173	-163	-154	-142	-132	-121	-113
Stockholders Equity	20	20	24	25	29	30	32	39	36	28	37	44
Liabilities And Stockholders Equity	27	26	32	33	38	38	40	53	52	47	57	63
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Temporary Equity Par Or Stated Value Per Share	-	-	-	-	-	-	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Temporary Equity Shares Issued	-	-	-	-	-	-	0	-	0	0	0	0
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Temporary Equity Shares Outstanding	-	-	-	-	-	-	0	-	0	0	0	0
Common Stock Shares Issued	28	27	27	27	27	23	22	22	20	18	18	18
Shares Outstanding	28	27	27	27	27	23	22	22	20	18	18	18

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-1.40%	-0.70%	13.29%	-	-	-	-	-	-	-	-	-
2025	4.09%	-24.82%	-61.78%	-27.24%	-27.96%	-31.90%	-12.72%	5.78%	0.00%	21.93%	27.19%	27.19%
2024	-12.26%	-18.11%	-20.33%	-12.14%	-34.01%	-35.40%	-16.75%	-24.79%	10.26%	-1.21%	6.07%	3.91%
2023	-	-	-	-4.62%	-22.72%	-20.66%	31.68%	48.80%	60.40%	-28.77%	-7.66%	-27.74%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	4.04	4.24	3.55	4.17	4.20	2.64	3.14	2.59	2.36	1.71	2.16	3.18
Quick Ratio	3.94	4.11	3.48	4.10	4.14	2.62	3.09	2.53	2.29	1.65	2.08	3.07
Working Capital	17.91M	17.43M	21.47M	23.31M	27.45M	13.03M	15.44M	22.03M	20.44M	12.37M	21.48M	31.26M
Leverage & Debt
Debt to Equity	0.32	0.32	0.38	0.31	0.31	0.27	0.23	0.36	0.42	0.63	0.51	0.41
Debt Ratio	0.24	0.24	0.27	0.24	0.23	0.22	0.19	0.27	0.29	0.38	0.33	0.29
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding TTM	-	-	19,947.25	10,267.45	17,330.20	9,365.90	40,228.21	5,059.81	9,326.79	-	3,602.72	-
Receivables Turnover TTM	0.00	0.00	0.02	0.04	0.02	0.04	0.01	0.07	0.04	-	0.10	-
Per Share Metrics
Diluted EPS TTM	-0.69	-1.56	-1.86	-1.88	-2.38	-1.81	-2.11	-2.04	-1.95	-1.91	-1.67	-1.52
Free Cash Flow Per Share TTM	-0.70	-0.76	-0.95	-0.93	-1.12	-1.45	-1.67	-1.28	-1.19	-1.02	-0.67	-0.79
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-	-	-94,766.00%	-102,752.00%	-112,458.00%	-83,046.00%	-304,535.71%	-51,933.75%	-30,722.76%	-20,316.57%	-15,409.84%	-12,055.36%
Net Profit Margin TTM	-	-	-91,866.00%	-99,774.00%	-111,016.00%	-81,592.00%	-300,585.71%	-51,590.00%	-30,684.55%	-20,412.43%	-15,548.19%	-12,246.88%
Growth Metrics
Net Revenue Growth (1Y)	-100.00%	-100.00%	257.14%	-37.50%	-59.35%	-70.41%	-92.75%	-64.29%	-55.91%	-32.13%	-48.40%	-49.09%
Net Income Growth (1Y)	-66.82%	1.97%	9.15%	20.87%	47.07%	18.26%	40.24%	50.45%	41.91%	28.09%	9.92%	-11.90%
EPS Growth (1Y)	-71.07%	-13.71%	-12.07%	-8.22%	21.88%	-5.24%	26.43%	34.22%	31.91%	27.52%	9.60%	-12.20%
Valuation Metrics
P/E TTM	-2.36	-0.72	-0.84	-1.10	-0.97	-4.31	-2.21	-2.64	-4.51	-6.14	-6.75	-4.44
P/B TTM	2.14	1.53	1.64	2.17	1.86	5.92	2.90	2.81	4.69	7.50	5.42	2.78
P/S TTM	-	-	772.44	1,100.63	1,076.39	3,513.91	6,652.85	1,360.01	1,384.48	1,253.32	1,049.03	544.27
Market Cap	43.55M	30.04M	38.62M	55.03M	53.82M	175.70M	93.14M	108.80M	170.29M	211.81M	202.46M	121.92M
Enterprise Value	25.14M	8.68M	13.87M	27.30M	20.45M	156.36M	72.22M	77.74M	144.20M	193.26M	176.54M	80.10M
Calculated Values
Free Cash Flow TTM	-18.72M	-20.20M	-23.62M	-24.73M	-26.08M	-32.71M	-33.36M	-25.75M	-23.03M	-18.32M	-11.98M	-14.27M
Net Debt	-18.41M	-21.36M	-24.75M	-27.73M	-33.37M	-19.34M	-20.92M	-31.06M	-26.09M	-18.55M	-25.93M	-41.81M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-09-30Purchase

Owner: Moss, David J

Title: Chief Financial Officer

Shares: 10,000

Price/Share: $5.29

Value: $52,900.00

Shares Owned: 1,285,869

Relationship: Officer,TenPercentOwner

Ownership: Direct

2024-09-12Purchase

Owner: Tesi, Raymond Joseph

Title: President and CEO

Shares: 15,380

Price/Share: $6.38

Value: $98,124.40

Shares Owned: 1,554,106

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2024-09-12Purchase

Owner: Moss, David J

Title: Chief Financial Officer

Shares: 7,690

Price/Share: $6.38

Value: $49,062.20

Shares Owned: 1,275,869

Relationship: Officer,TenPercentOwner

Ownership: Direct

2024-06-25Purchase

Owner: Juda, Scott

Title: -

Shares: 5,000

Price/Share: $7.27

Value: $36,350.00

Shares Owned: 71,603

Relationship: Director

Ownership: Indirect

2024-04-19Purchase

Owner: Juda, Scott

Title: -

Shares: 29,603

Price/Share: $8.32

Value: $246,296.96

Shares Owned: 66,603

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-09-30	Moss, David J	Officer,TenPercentOwner	Chief Financial Officer	Direct	Purchase	10,000	5.29	$52,900.00	1,285,869	4
2024-09-12	Tesi, Raymond Joseph	Director,Officer,TenPercentOwner	President and CEO	Direct	Purchase	15,380	6.38	$98,124.40	1,554,106	4
2024-09-12	Moss, David J	Officer,TenPercentOwner	Chief Financial Officer	Direct	Purchase	7,690	6.38	$49,062.20	1,275,869	4
2024-06-25	Juda, Scott	Director	-	Indirect	Purchase	5,000	7.27	$36,350.00	71,603	4
2024-04-19	Juda, Scott	Director	-	Direct	Purchase	29,603	8.32	$246,296.96	66,603	4/A
2024-04-19	Lowdell, Mark William	Officer,TenPercentOwner	Chief Scientific Officer	Direct	Purchase	14,423	8.32	$119,999.36	1,510,806	4/A
2024-04-19	Moss, David J	Officer,TenPercentOwner	CFO, Treasurer & Secretary	Direct	Purchase	18,028	8.32	$149,992.96	1,268,179	4/A
2024-04-19	Tesi, Raymond Joseph	Director,Officer,TenPercentOwner	President and CEO	Direct	Purchase	18,028	8.32	$149,992.96	1,538,726	4/A
2023-11-10	Juda, Scott	Director	-	Indirect	Purchase	7,000	6.95	$48,650.00	37,000	4
2023-07-12	Schroeder, Timothy J	Director	-	Indirect	Sale	10,000	11.01	$110,100.00	82,187	4
2023-03-17	Moss, David J	Officer,TenPercentOwner	CFO, Treasurer & Secretary	Direct	Purchase	2,500	6.43	$16,075.00	1,250,151	4
2022-05-27	Moss, David J	Officer,TenPercentOwner	CFO, Treasurer & Secretary	Direct	Purchase	3,000	6.79	$20,370.00	1,247,651	4
2022-05-26	Tesi, Raymond Joseph	Director,Officer,TenPercentOwner	President and CEO	Direct	Purchase	6,300	6.41	$40,383.00	1,520,698	4
2021-11-17	Juda, Scott	Director	-	Indirect	Purchase	2,500	13.55	$33,875.00	30,000	4
2021-11-03	Lowdell, Mark William	Officer,TenPercentOwner	Chief Scientific Officer	Direct	Sale	701	20.00	$14,020.00	1,472,793	4
2021-11-03	Tesi, Raymond Joseph	Director,Officer,TenPercentOwner	President and CEO	Direct	Sale	3,626	20.00	$72,520.00	1,490,674	4
2021-11-03	Moss, David J	Officer,TenPercentOwner	CFO, Treasurer & Secretary	Direct	Sale	1,025	20.00	$20,500.00	1,219,158	4
2021-10-27	Tesi, Raymond Joseph	Director,Officer,TenPercentOwner	President and CEO	Direct	Sale	6,517	20.00	$130,340.00	1,494,300	4
2021-10-27	Lowdell, Mark William	Officer,TenPercentOwner	Chief Scientific Officer	Direct	Sale	2,357	20.00	$47,140.00	1,473,494	4
2021-10-27	Moss, David J	Officer,TenPercentOwner	CFO, Treasurer & Secretary	Direct	Sale	2,079	20.00	$41,580.00	1,220,183	4
2021-10-25	Moss, David J	Officer,TenPercentOwner	CFO, Treasurer & Secretary	Direct	Sale	13	20.00	$260.00	1,222,262	4
2021-10-22	Lowdell, Mark William	Officer,TenPercentOwner	Chief Scientific Officer	Direct	Sale	400	20.00	$8,000.00	1,475,851	4
2021-10-22	Tesi, Raymond Joseph	Director,Officer,TenPercentOwner	President and CEO	Direct	Sale	23,616	20.00	$472,320.00	1,500,817	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

20.08%

Inst. Shares: 5,338,854

Shares Outstanding: 26,585,258

2025-12-31

20.44%

Inst. Shares: 5,059,846

Shares Outstanding: 24,757,545

2025-09-30

17.32%

Inst. Shares: 4,605,767

Shares Outstanding: 26,585,258

2025-06-30

23.24%

Inst. Shares: 5,414,722

Shares Outstanding: 23,298,455

2025-03-31

25.87%

Inst. Shares: 5,820,181

Shares Outstanding: 22,496,191

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	5,338,854	26,585,258	20.08%
2025-12-31	5,059,846	24,757,545	20.44%
2025-09-30	4,605,767	26,585,258	17.32%
2025-06-30	5,414,722	23,298,455	23.24%
2025-03-31	5,820,181	22,496,191	25.87%
2024-12-31	6,136,723	19,944,304	30.77%
2024-09-30	5,320,764	20,185,676	26.36%
2024-06-30	4,519,874	19,307,323	23.41%
2024-03-31	2,566,630	18,026,473	14.24%
2023-12-31	2,109,937	17,980,791	11.73%
2023-09-30	1,734,166	18,008,295	9.63%
2023-06-30	1,936,910	17,945,995	10.79%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Inmune Bio, Inc. (INMB) — SEC Financial Statements & Analysis

Inmune Bio, Inc. (INMB) is a biological products, (no diagnostic substances) company, incorporated in NV. Inmune Bio, Inc. trades on Nasdaq as: INMB. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Inmune Bio, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.32x, a Price-to-Sales (P/S) ratio of 772.44x (TTM), a Price-to-Book (P/B) ratio of 2.14x (TTM), at a market cap of $43.55M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 0.32x
P/S TTM: 772.44x
P/B TTM: 2.14x
Market Cap: $43.55M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Inmune Bio, Inc. in?

Inmune Bio, Inc. (INMB) operates in the Biological Products, (No Diagnostic Substances) industry.

What is INMB's market cap?

Inmune Bio, Inc. (INMB) has a market capitalization of $43.55M as of 2026-06-30.

What exchange does INMB trade on?

Inmune Bio, Inc. (INMB) trades on the Nasdaq.

Where is Inmune Bio, Inc. incorporated?

Inmune Bio, Inc. is incorporated in NV.

Inmune Bio, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Inmune Bio, Inc. (INMB) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.
Main Street's price.

Inmune Bio, Inc. (INMB) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.